- Email: [email protected]
Chinese desalination plant employs ItN Nanovation's membrane technology
NEWS to replicate our Australian successes around the world.’ ‘The desalination and water reuse capabilities and experience of Osmoflo’s team are first class and with the ability to fully utilise these skills via the Hitz network, we expect significant opportunities for growth.’ The majority share acquisition provides significant growth opportunities for Osmoflo and will enable the company to tap into Hitz’s large international network. Osmoflo will be able to offer its customers and the market a substantially increased range of products and technologies, and will be able to access markets within the desalination and industrial water treatment industry with which it has previously not been involved. The Australian firms says that whilst using the Hitz network it will continue to operate separately under its valued “Osmoflo” brand name and with its experienced team based throughout Australia and internationally. As reported earlier this year, Hitz acquired 70% of Osmoflo’s shares, held by Osmoflo founders Annie and Marc Fabig. Marc remains active in the company as a non-executive director. The remaining 30% of shares continue to be held by Marubeni Water Australia Pty Ltd, a subsidiary of Japan’s Marubeni Corp. Contacts: Hitachi Zosen Corp, 7–89, Nankokita 1-chome, Suminoe-ku, Osaka 559-8559, Japan. Tel: +81 6 6569 0001, www.hitachizosen.co.jp/english/index.html Osmoflo Pty Ltd, 382 Diment Road, Burton, 5110 South Australia, Australia. Tel: +61 8 8282 9700, www.osmoflo.com
Chinese desalination plant employs ItN Nanovation’s membrane technology
G
ermany’s ItN Nanovation Ag and its major shareholder Shanghai Safbon Investment Co Ltd, are developing what they claim is one of the world’s largest water plants for the desalination of sea water. Based in the city of Ying Kou, in the north of China, the facility uses ItN Nanovation’s process based on ceramic flat-sheet membranes for the pre-filtration of sea water before reverse osmosis (RO). With a total capacity of more than 400 000 m3 (105.7 million gallons) a day, the plant will use more than 100 000 m2 (1.1 mil4
Membrane Technology
lion ft2) of ceramic flat-sheet membranes. The project is divided into four equal phases, with the first one going into operation in 2019. The project is worth US$20 million to ItN Nanovation. The ceramic flat-sheet membranes that will be used in the first phase are scheduled to be delivered in 2018. ItN Nanovation says that it is seeing this project as the initial application of its technology in close cooperation with its relatively new investor. Further projects – handled either by ItN alone or developed together with SafBon – are already under way.
‘This joint laboratory further strengthens WuXi Biologics’ capabilities in integrated biologics discovery, development and manufacturing services,’ commented Dr Chris Chen, CEO, WuXi Biologics. ‘WuXi Biologics is committed to providing a seamless, truly one-stop service for our partners and clients, from concept to commercialisation.’ Contacts: Merck KgaA, Frankfurter Strasse 250, 64293 Darmstadt, Germany. Tel: +49 6151 720, www.merckgroup.com
Contact: ItN Nanovation Ag, Untertürkheimer Str. 25, 66117 Saarbrücken, Germany. Tel: +49 681 5001-460, www.itn-nanovation.com
WuXi Biologics, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China. Tel: +86 400 820 0985, www.wuxibiologics.com
Merck supplies single-use systems to WuXi Biologics’ pilot plant in Shanghai
ACWA MBR plant delivers 99% water recovery at Saudi oil field
G
A
ermany’s Merck KgaA, a major science and technology company that operates in healthcare, life sciences and the performance materials sector, is supplying its Mobius singleuse systems and technologies to equip a non-GMP pilot plant in Shanghai, China, run by WuXi Biologics. The facility services the integrated biologics technology platform company’s customers and is intended to accelerate development of biopharmaceuticals products. ‘The demand for biologics is growing, and the ability to successfully bring these therapeutics to market relies on rapid, cost-effective development and manufacturing,’ explained Daniel Stamm, who is the head of Global Process Solutions Commercial, Life Science, at Merck. ‘Incorporation of our Mobius single-use technologies in this new facility will help WuXi Biologics strengthen robust processes and accelerate progress from pilot to commercial scale.’ The plant features Mobius single-use products across the entire upstream and downstream workflow, including buffer and media preparation, fed-batch and perfusion bioreactors, clarification, chromatography, virus clearance, ultrafiltration/diafiltration, formulation and fill. According to the companies, this singleuse workflow delivers increased efficiency and ease-of-use with improved process economics essential to the development and manufacture of biologics.
CWA Emirates, part of the ACWA Group – a water and wastewater technology and products provider – recently completed a wastewater treatment plant for Saudi Aramco, an exporter of crude oil and natural gas, to support the residential complex at the company’s expanding Shaybah oil field in the Empty Quarter of Saudi Arabia. With the emphasis on the highest levels of water recovery, essential in the remote and challenging conditions of this area, the new plant incorporates the latest membrane bioreactor (MBR) technology to provide increased capacity and environmental performance – replacing a conventional sewage treatment plant originally built by ACWA in 1997, which is now out of date. The new plant is designed to treat a works flow of 750 m3 (198 129 gallons) per day, with sufficient additional capacity to support growing demand at the Shaybah Field and, says ACWA, is delivering 99% water recovery with high-quality effluent for use in irrigation, in line with Aramco’s strict environmental quality standards. Under the contract, ACWA has been responsible for all aspects of design, engineering, installation and commissioning of the plant, including an operation and maintenance package to provide assistance and training. The twenty-month project was handed over at the end of last year.
May 2017
Chinese desalination plant employs ItN Nanovation’s membrane technology
G
ermany’s ItN Nanovation Ag and its major shareholder Shanghai Safbon Investment Co Ltd, are developing what they claim is one of the world’s largest water plants for the desalination of sea water. Based in the city of Ying Kou, in the north of China, the facility uses ItN Nanovation’s process based on ceramic flat-sheet membranes for the pre-filtration of sea water before reverse osmosis (RO). With a total capacity of more than 400 000 m3 (105.7 million gallons) a day, the plant will use more than 100 000 m2 (1.1 mil4
Membrane Technology
lion ft2) of ceramic flat-sheet membranes. The project is divided into four equal phases, with the first one going into operation in 2019. The project is worth US$20 million to ItN Nanovation. The ceramic flat-sheet membranes that will be used in the first phase are scheduled to be delivered in 2018. ItN Nanovation says that it is seeing this project as the initial application of its technology in close cooperation with its relatively new investor. Further projects – handled either by ItN alone or developed together with SafBon – are already under way.
‘This joint laboratory further strengthens WuXi Biologics’ capabilities in integrated biologics discovery, development and manufacturing services,’ commented Dr Chris Chen, CEO, WuXi Biologics. ‘WuXi Biologics is committed to providing a seamless, truly one-stop service for our partners and clients, from concept to commercialisation.’ Contacts: Merck KgaA, Frankfurter Strasse 250, 64293 Darmstadt, Germany. Tel: +49 6151 720, www.merckgroup.com
Contact: ItN Nanovation Ag, Untertürkheimer Str. 25, 66117 Saarbrücken, Germany. Tel: +49 681 5001-460, www.itn-nanovation.com
WuXi Biologics, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China. Tel: +86 400 820 0985, www.wuxibiologics.com
Merck supplies single-use systems to WuXi Biologics’ pilot plant in Shanghai
ACWA MBR plant delivers 99% water recovery at Saudi oil field
G
A
ermany’s Merck KgaA, a major science and technology company that operates in healthcare, life sciences and the performance materials sector, is supplying its Mobius singleuse systems and technologies to equip a non-GMP pilot plant in Shanghai, China, run by WuXi Biologics. The facility services the integrated biologics technology platform company’s customers and is intended to accelerate development of biopharmaceuticals products. ‘The demand for biologics is growing, and the ability to successfully bring these therapeutics to market relies on rapid, cost-effective development and manufacturing,’ explained Daniel Stamm, who is the head of Global Process Solutions Commercial, Life Science, at Merck. ‘Incorporation of our Mobius single-use technologies in this new facility will help WuXi Biologics strengthen robust processes and accelerate progress from pilot to commercial scale.’ The plant features Mobius single-use products across the entire upstream and downstream workflow, including buffer and media preparation, fed-batch and perfusion bioreactors, clarification, chromatography, virus clearance, ultrafiltration/diafiltration, formulation and fill. According to the companies, this singleuse workflow delivers increased efficiency and ease-of-use with improved process economics essential to the development and manufacture of biologics.
CWA Emirates, part of the ACWA Group – a water and wastewater technology and products provider – recently completed a wastewater treatment plant for Saudi Aramco, an exporter of crude oil and natural gas, to support the residential complex at the company’s expanding Shaybah oil field in the Empty Quarter of Saudi Arabia. With the emphasis on the highest levels of water recovery, essential in the remote and challenging conditions of this area, the new plant incorporates the latest membrane bioreactor (MBR) technology to provide increased capacity and environmental performance – replacing a conventional sewage treatment plant originally built by ACWA in 1997, which is now out of date. The new plant is designed to treat a works flow of 750 m3 (198 129 gallons) per day, with sufficient additional capacity to support growing demand at the Shaybah Field and, says ACWA, is delivering 99% water recovery with high-quality effluent for use in irrigation, in line with Aramco’s strict environmental quality standards. Under the contract, ACWA has been responsible for all aspects of design, engineering, installation and commissioning of the plant, including an operation and maintenance package to provide assistance and training. The twenty-month project was handed over at the end of last year.
May 2017